Home / Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide / Italy
IT ATC C09DX03 · updated 2 Nov 2026
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide shortage in Italy
Is there an Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide shortage in Italy?
Yes. As of 2 Nov 2026, 8 Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide products are reported short in Italy, the first since 11 Oct 2024. The company estimate for the return is 10 Dec 2026. Main reason: increased demand.
Also short in Spain, Belgium. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | GADUAR | ZENTIVA ITALIA S.R.L. | 11 Oct 2024 | not given | Increased demand Elevata richiesta |
| IT | GADUAR | ZENTIVA ITALIA S.R.L. | 11 Oct 2024 | not given | Increased demand Elevata richiesta |
| IT | GADUAR | ZENTIVA ITALIA S.R.L. | 13 Apr 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | GADUAR discontinuation | ZENTIVA ITALIA S.R.L. | 5 Sep 2026 | not given | Increased demand Elevata richiesta |
| IT | OLMETRIVART discontinuation | MYLAN S.P.A. | 14 Sep 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | OLMETRIVART | MYLAN S.P.A. | 14 Oct 2026 | 10 Dec 2026 | Manufacturing problem Problemi produttivi |
| IT | GADUAR anticipated | ZENTIVA ITALIA S.R.L. | 16 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | SEVITREX anticipated | DAIICHI SANKYO ITALIA S.P.A. | 27 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.